ATHERSYS, INC 8-K 2015
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 1, 2015
(Exact name of registrant as specified in charter)
Registrants telephone number, including area code: (216) 431-9900
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 8.01. Other Events.
On March 1, 2015, Athersys, Inc. (Athersys) announced a collaboration with Chugai Pharmaceutical Co., Ltd. (Chugai) to develop and commercialize MultiStem® cell therapy for ischemic stroke in Japan. A copy of the press release issued jointly by Athersys and Chugai announcing the collaboration is filed as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 2, 2015